Document B8vmDDd9NxXOMgpov30OZxdVw

TEH 0412515 WjfegStJI**,'-- ( a i/*-//yfr 2 4 S V QW % WV. / if "\ / \ CC: 3. M. Pierrard-E5D-L135G W. F. Wagner-ESD-L2305 D. W. Marquardt-ESD-L51B6 IC 52 - Applied Statistics March 17, 1986 3,, G. PARTAIN CHEMICALS 4 PIGMENTS BRANDYWINE 16254 CASAC MEETING ON AIR QUALITY CRITERIA FOR LEAD - TRIP REPORT I attended the meeting of the Clean Air Scientific Advisory Committee (CASAC) of EPA's Science Advisory Board on March 11-12, 1986 and presented public comments (attached) on Du Pont's analyses of the blood pressure-blood lead (BP-BPb) association reflected in the draft Addendum. The oral comments were drawn from the written comments, which you previously received, prepared by 3ack Pierrard and myself on the Addendum. The meeting agenda and list of CASAC members are attached. The purpose of the meeting was for CASAC to review the February 1986 Addendum to the Air Quality Criteria Document for Lead, which is based on recently published information relating blood lead to blood pressure and stature; and, to review the Lead Staff Paper, which is intended to evaluate and interpret the most critical scientific and technical information from the Criteria Document leading to a revision of the National Ambient Air Quality Standard for Lead. Our comments discussed at the May 9, 1985 CASAC Meeting were well received and led to relegation of the BP-BPb discussion then in the Corrigenda to an Addendum subject to review of Du Pont's comments. Our oral comments on March 12, 1986 were mainly directed at the EPA initiated review process on our analyses of May 9, 1985. Not unexpectedly, we were unable to achieve our ultimate goal, deletion of the Addendum. However, our comments and presence were felt. Dr. Ware, CASAC statistical consultant, acknowledged the importance of the issues raised by Du Pont and the results provided, stated he was not persuaded that a BP-BPb association exists by the evidence at hand, and recommended more work should be done to resolve the significance and magnitude of the BP-BPb association with Du Pont's involvement. We also received support from other members of CASAC as well as support in writing by other statisticians reviewing EPA's analyses and Du Pont's. My 15 minute presentation extended to 45 minutes with discussion. The important benefit of our comments and participation is that C. G. Pfeifer TEH 0412516 DUP050453568 N 30998.01 2 March 17, 1986 Jo 8 . r*art ain our position and the supporting comments are a fully documented part of the public record. A transcript of the proceedings has been requested for future reference. CASAC was extremely critical of the Staff Paper and requested major revisions. Some favorable comments were expressed on the probability risk assessment material. Dr. Gale Hoffnagle, TRC, presented public comments for Lead Industries Association on Exposure to Airborne Lead From Stationary Sources; An Evaluation of Proposed National Ambient Air Quality Standards for Lead. Included in this report is a cost-benefit analysis on compliance costs for the TEL facility at Chambers Works for meeting a 0.5^g/nr standard. Compliance costs are estimated at $6.5MM opposite benefits of $63M. Follow-up to this meeting is as follows; o CASAC requested that EPA revise Addendum to more fairly present scientific findings in time for CASAC meeting in April 1986. Then CASAC will be prepared to close on both the Criteria Document and the Addendum for publication and distribution. This time frame, if met, precludes any further resolution of the issues raised by Du Pont. There will be no public review of this Addendum revision. o Another draft of the Staff Paper is required and CASAC will meet to review it. A public comment period probably will occur, although it was not mentioned specifically. o Revised primary and secondary National Ambient Air Quality Standards for Lead are expected to be promulgated in mid 1987. There are a variety of future activities that Jack and I perhaps should be involved in. These include; o Comments on Current Staff Paper due May 1986. o Comments on revised Addendum. Although this will not be available for public review, I requested. Dr. Grant, ECAO Director, send me a copy of this revision. If a balanced view of BP-BPb is not given, it will be critical to respond in time before CASAC closes on the Addendum. This would be our last chance to impact on it. o Dr. Grant and Dr. Lippman will ask for Du Pont1s involvement in a process to resolve the magnitude of the BP-BPb effect, if these effects are to be used by OAQPS in assessing cardiovascular risk. o Don Diggs and others have strongly suggested we publish our results refuting the BP-BPb association portrayed in key papers of Harlan, et al (1985) and Pirkle, et al (1985). o There undoubtedly will be a comment period on the next revision of the staff paper. TEH 0412517 C. G. Pfeifer DUP050453569 March 17, 1y06 J. 8. Par tain We need your guidance on the extent to which you wish Jack and I to pursue these activities. I believe our efforts and involvement on the BP-BPb association have been critical to establishing a defensible position on this health-effect issue. Our present work request will be nearly exhausted as a result of the most recent efforts. Please advise on your support of continued efforts for representing Du Pont on lead regulation issues. ENGINEERING SERVICE DIVISION Applied Statistics Group C. G. Pfeifer Consultant Supervisor CGP:lsw Atchs 5.9 TEH 0412518 DUP050453570 i i'':i r / r-: <- r,;.. lean Air Scientific: Advisory Cs'srrsr'i Lead NAAQS Review Committee U.S. E.P.A. Environmental Research Center Main Auditorium Alexander Drive and Route 54 Research Triangle Park, NC Open Meeting - March 11-12, 1986 Tuesday, March 11 9:30 a.m. 9:45 11:30 11:45 1:00 p.m. 1:30 3:00 3:15 4:30 Welcome and Opening Remarks Dr. Lippmann, CASAC Chairman Discussion of the Addendum to the Lead Criteria Document Dr. Grant, ECAO Dr. Weil, ECAO Brief Presentation of Regression on Blood Lead and Blood Pressure Dr. Joel Schwartz, OP PE Lunch Introduction and Overview of the Lead Staff Paper Mr. O'Connor, OAQPS Mr. Jordan, OAQPS Mr. Haines, OAQPS Mr. Cohen, OAQPS Discussion of Staff Paper Break Exposure Analysis and Discussion Ms. Sledge, OAQPS Comments from the Public - Dr. Jerome Cole, ILZRO - Dr. Gale Hoffnagle, TRC - Dr. Harvey Gonick, Cedars Sinai Medical Center - Mr. Richard Smith, U.S. Bureau of Mines - Dr. Charles Pfeifer, du Pont 5:30 Recess 7:00 CASAC Dinner at Slugs-at-the-Pines (Cash Bar at 7:00, Dinner at 8:00) TEH 0412519 DUP050453571 Wednesday, March 12 9:00 a.m. Lead Risk Assessment 10:00 Break 10:15 Committee Discussion 11:00 Summarization - Review of Closure Issues - Future Activities 12:30 p.m. Adjourn Dr. Wallsten Dr. Whitfield Dr. Lippmann TEH 0412520 DUP050453572 V 4. U.S. ENVIRONMENTAL PRO'Ii.CT ION AGENCY CLEAN AIR SCIENTIFIC ADVISORY COMMITTEE SCIENCE ADVISORY BOARD Subcommittee on Lead Chairman Dr. Morton Lippmann Professor Department of Environmental Medicine NYU Medical Center Tuxedo, New York 10987 ji& -E--x--e--c--u--t-iv--e----S--e--c--r-e--t-a--ry /y t^Mr. Robert Flaak '^Science Advisory Board (A-101F) U.S. Environmental Protection Agency 401 M Street, S.W. Washington, D.C. 20460 Panel Members *yf Dr. Carol R. Angle ^ Professor of Pediatrics and Director UNMC Toxicology Program University of Nebraska Medical Center COP - Room 4037A 42nd and Dewey Avenue Omaha, Nebraska 68105 l/t)r. Robert Frank ^/Professor of Environmental Health Sciences Johns Hopkins School of Hygiene and Public Health 615 N. Wolfe Street Baltimore, Maryland 21205 '/y Dr. J. Julian Chisolm, Jr. \s Associate Professor of Pediatrics The Kennedy Institute 707 North Boardway Baltimore, Maryland 21205 Prof. A. Myrick Freeman III Department of Economics Bowdoin College Brunswick, Maine 04011 * Dr. Anita S. Curran Commissioner Westchester County Health Department 112 East Post Road White Plains, New York 10601 \/y Dr. Robert Goyer Deputy Director NIEHS P.0. 12233 RTp ] North Carolina 27709 */, Dr. Ben B. Ewing l/ Professor of Environmental Engineering Institute for Environmental Studies University of Illinois 408 S. Goodwin Urbana, Illinois 61801 Dr. Paul B. Hammond y Professor of Environmental Health University of Cincinnati College of Medicine Kettering Laboratory 3223 Eden Avenue Cincinnati, Ohio 45267-0056 TEH 0412521 DUP050453573 s. \` Ll'iyn li. Ih j it !;ihrevs y/ Professor Lmrritus University of Illinois Urbana-Champaign 603 East Daniel Champaign, Illinois 61820 y * Dr. Warren B. Johnson y. Director, Atmospheric Science Center SRI International 333 Ravenswood Avenue Menlo Park, California 94025 i Dr. Paul Kotin X Adjunct Professor of Pathology University of Colorado Medical School 4505 S. Yosemite #339 Denver, Colorado 80237 yj Dr. Timothy Larson Environmental Engineering and Science Program Department of Civil Engineering FX-10 University of Washington Seattle, Washington 98195 Dr. Kathryn R. Mahaffey v Chief, Priorities Research and Analysis Branch (C-15) NI0SH 4676 Columbia Parkway Cincinnati, Ohio 45226 Prof. M. Granger Morgan v Head, Department of Engineering and Public Policy Carnegie-Mel Ion University Pittsburgh, Pennsylvania 15253 * Unable to attend meeting ( f ' ^1 o i . itV* I \ v' lAparLinen! of Lconomics Stanford University Stanford, California 94305 X Dr. D. Warner North y. Principal Decision Focus Inc., Los Altos Office Center, Suite 200 4984 El Camino Real Los Altos, California 94022 ^Dr. Robert D. Rowe ice President, Environmental and Resource Economics Energy and Resource Consultants Inc. 207 Canyon Boulevard Boulder, Colorado 80302 % * Prof. Richard M. Royal! K Department of Biostatistics Johns Hopkins University 615 North Wolfe Street Baltimore, Maryland 21205 v/yDr. Ellen K. Silbergeld %/ Chief Toxics Scientist Toxic Chemicals Program Environmental Defense Fund 1525 18th Street, N.W. Washington, D.C. 20036 Dr. James H. Ware / Associate Professor Harvard School of Public Health Department of Biostatistics 677 Huntington Avenue Boston, Massachusetts 02115 V/Dr. Jerry Wesolowski I/Air and Industrial Hygiene Lab California Department of Health 2151 Berkeley Way Berkeley, California 94704* TEH 0412522 DUP050453574